| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879510 | The Annals of Thoracic Surgery | 2008 | 8 Pages |
Abstract
Full-dose aprotinin use was not associated with myocardial infarction, neurologic dysfunction, renal insufficiency, or death after coronary or valve operations. We observed less postoperative bleeding and blood product transfusion, and early extubation with the use of aprotinin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Dumbor L. FRCS (C-Th), MD, Alexander R. FRCS (C-Th), MD, Michael E. FRCS, Steven FRCS (C-Th), Levant FRCS,